- STMicroelectronics NV STM and Korean medical device manufacturer Nu Eyne jointly announced a Nu Eyne wearable therapy device for eye care powered by an STM32WB55 dual-core Bluetooth LE (BLE) microcontroller (MCU).
- Nu Eyne's recently launched CELLENA wearable device uses electric current and light emitted to the eyes and associated nerves to relieve eye dryness and fatigue.
- The CELLENA device relies on the dual-core architecture of the STM32WB55 MCU for wireless connectivity and real-time processing.
- ST's MCU also delivers multiple security mechanisms, including user data protection and encrypted firmware update over BLE with its embedded security features.
- Price Action: STM shares traded higher by 0.81% at $43.69 in the premarket session on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
